|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/62 | |
| C07K 19/00 | |||
| C07K 16/24 | |||
| C12N 15/85 | |||
| A61K 35/17 |
| (11) | Number of the document | 3333264 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16833374.8 |
| Date of filing the European patent application | 2016-08-05 | |
| (97) | Date of publication of the European application | 2018-06-13 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/KR2016/008632 |
| Date | 2016-08-05 |
| (87) | Number | WO 2017/023138 |
| Date | 2017-02-09 |
| (30) | Number | Date | Country code |
| 20150110788 | 2015-08-05 | KR |
| (72) |
KONG, Seogkyoung, KR
|
| (73) |
CellabMED Inc.,
No 1301-1, 38-21, Digital-ro 31-gil, Guro-gu, Seoul,
KR
|
| (54) | CHIMERIC ANTIGEN RECEPTOR, AND T CELLS IN WHICH CHIMERIC ANTIGEN RECEPTOR IS EXPRESSED |
| CHIMERIC ANTIGEN RECEPTOR, AND T CELLS IN WHICH CHIMERIC ANTIGEN RECEPTOR IS EXPRESSED |